MedTrace Logo

Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement

NCT03107897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-06-09

No results posted yet for this study

Summary

In this pilot study, investigators aim to identify patients undergoing TAVR who are at elevated risk for adverse clinical events due to decreased exertional capacity and physical deconditioning. Investigators aim to determine if monitored pre-procedural physical therapy is safe in these patients. Lastly, investigators aim to assess the efficacy of prehabilitation

1. to improve physical functioning by the time of TAVR and to sustain benefit through 30 days post-procedure; and
2. to determine its effect on post-procedural length-of-stay, clinical outcomes, and quality of life.

Conditions

  • Aortic Valve Stenosis

Interventions

OTHER

Pre-habilitation

Eight - Twelve visits to physical therapy prior to their TAVR procedure.

Sponsors & Collaborators

  • WellSpan Health

    lead OTHER

Principal Investigators

  • James Harvey, MD · Wellspan York Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-17
Primary Completion
2020-08-09
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107897 on ClinicalTrials.gov